Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of protein digestive capacity and utilisation during ontogeny of Senegalese sole larvae: a tracer study using in vivo produced radiolabelled peptide fractions.

Communications in agricultural and applied biological sciences·2014
Same author

Approaching families for organ donation-intensivists' perspectives.

Anaesthesia and intensive care·2012
Same author

Levosimendan in septic shock: a case series.

British journal of anaesthesia·2007
Same author

Cardiac arrest: a late complication of glucose-insulin-potassium (GIK) therapy.

Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine·2006
Same author

Massive air embolism with pulmonary arterio-bronchial fistula and ventricular septal defect.

Anaesthesia and intensive care·1997
Same author

Complications of resuscitation: mediastinal blood transfusion.

British journal of hospital medicine·1997

Related Experiment Video

Updated: Jul 10, 2026

A Porcine Model of Acute Autologous Pulmonary Embolism
07:44

A Porcine Model of Acute Autologous Pulmonary Embolism

Published on: September 6, 2024

Levosimendan in acute pulmonary embolism.

B P Powell1, D Simes

  • 1Fremantle Intensive Care Unit, Fremantle Hospital, Fremantle, Western Australia, Australia.

Anaesthesia and Intensive Care
|October 16, 2007
PubMed
Summary

Levosimendan effectively treats cardiac failure and right ventricle issues. This case study highlights its use in managing life-threatening pulmonary embolism, showcasing its potential in critical cardiovascular conditions.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Levosimendan is recognized for treating ischemic cardiac failure and myocardial stunning.
  • Emerging research indicates positive effects of levosimendan on right ventricular function in various models.

Observation:

  • A critical case involving a life-threatening pulmonary embolism was encountered.
  • The patient's condition necessitated advanced hemodynamic support.

Findings:

  • Levosimendan administration was instrumental in supporting the patient through the pulmonary embolism.
  • The drug's inotropic and vasodilatory properties were leveraged for hemodynamic stabilization.

Implications:

  • This case suggests levosimendan may be a valuable therapeutic option for severe pulmonary embolism.

Related Experiment Videos

Last Updated: Jul 10, 2026

A Porcine Model of Acute Autologous Pulmonary Embolism
07:44

A Porcine Model of Acute Autologous Pulmonary Embolism

Published on: September 6, 2024

  • Further investigation into levosimendan's role in acute right heart failure secondary to pulmonary embolism is warranted.